In addition to Abbott and Thermo, consider the other players who have the same test already approved for use by the FDA:
- BD Veritor CoV-2 & Flu A & B
- Applied Biosystem TaqPath Combo COVID-19, FluA, FluB
- Lucira COVID - Influenza A & B
- Quidel Sophia 2 Flu+SARS
- Roche Liat SARA-Cov-2 + Influenza A/B Multiplex
LUMOS isn't even at the starting line for Virdex revenue and all of the other racers packed up, went home, and are looking for the next run.
I am beginning to think the change in leadership here was a bad move. I was hoping for a fresh outlook and strategic moves.
Where the previous admin "failed fast" and moved on, this leadership seems to fail hard and not admit it to themselves. Dragging investors down while saying "everything is fine".
- Forums
- ASX - By Stock
- LDX
- Ann: Change in substantial holding
Ann: Change in substantial holding, page-14
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LDX (ASX) to my watchlist
|
|||||
Last
4.2¢ |
Change
-0.004(8.70%) |
Mkt cap ! $21.17M |
Open | High | Low | Value | Volume |
4.6¢ | 4.6¢ | 4.2¢ | $230.1K | 5.259M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 534989 | 4.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.3¢ | 221428 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 534989 | 0.042 |
4 | 685800 | 0.041 |
3 | 425001 | 0.040 |
1 | 120000 | 0.039 |
2 | 500000 | 0.038 |
Price($) | Vol. | No. |
---|---|---|
0.043 | 221428 | 2 |
0.044 | 300000 | 1 |
0.046 | 600000 | 2 |
0.047 | 100000 | 1 |
0.048 | 218015 | 3 |
Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
Featured News
LDX (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online